ClinicalTrials.Veeva

Menu

Collaborative Targeted Case Management in Improving Functional Status in Patients with Stage III-IV Cancer

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Malignant Neoplasm
Cognitive/functional Effects
Pain

Treatments

Procedure: quality-of-life assessment
Procedure: assessment of therapy complications
Other: case management
Behavioral: telephone-based intervention
Procedure: management of therapy complications
Other: educational intervention
Other: questionnaire administration
Procedure: physical therapy

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01721343
R01CA163803 (U.S. NIH Grant/Contract)
NCI-2012-01603 (Registry Identifier)
MC1193

Details and patient eligibility

About

This randomized clinical trial studies collaborative targeted case management in improving functional status in patients with stage III-IV cancer. Collaborative targeted case management may improve functional mobility, improve quality of life, and reduce pain and health care utilization in patients with advanced cancer

Full description

PRIMARY OBJECTIVES:

I. Establish the comparative effectiveness of the Collaborative Care to Preserve Performance in Cancer (COPE) trial arms in preserving functional mobility.

II. To assess the comparative cost-effectiveness and cost-utility of the COPE interventions.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM I: Patients undergo enhanced usual care comprising telephonic monitoring with monthly status reports provided to their oncology care teams for 6 months.

ARM II: Patients undergo enhanced usual care as in Arm I and participate in an individualized conditioning program delivered telephonically by the Fitness Care Manager (FCM) and adapted, as required, by a local physical therapist for 6 months.

ARM III: Patients undergo enhanced usual care as in Arm I, participate in an individualized conditioning program coordinated by the FCM as in Arm II, and receive optimized pain management through a nurse Pain Care Manager (PCM) for 6 months.

Enrollment

516 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of stage III or stage IV cancer
  • Life expectancy > 6 months
  • Ambulatory Post Acute Care (APC) score between 53 and 66
  • Ability to complete questionnaire(s) by themselves or with assistance
  • Provide informed written consent
  • Have working phone to communicate with study team
  • Fluent in English
  • Sufficient auditory acuity
  • Intact cognitive status

Exclusion criteria

  • Patient is within 2 months of a major surgical procedure

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

516 participants in 3 patient groups

Arm I (enhanced usual care)
Experimental group
Description:
Patients undergo enhanced usual care comprising telephonic monitoring with monthly status reports provided to their oncology care teams for 6 months.
Treatment:
Procedure: management of therapy complications
Procedure: management of therapy complications
Other: questionnaire administration
Procedure: assessment of therapy complications
Procedure: management of therapy complications
Behavioral: telephone-based intervention
Procedure: assessment of therapy complications
Procedure: assessment of therapy complications
Procedure: quality-of-life assessment
Arm II (enhanced usual care, RCM)
Experimental group
Description:
Patients undergo enhanced usual care as in Arm I and participate in an individualized conditioning program delivered telephonically by the Fitness Care Manager (FCM) and adapted, as required, by a local physical therapist for 6 months.
Treatment:
Procedure: management of therapy complications
Procedure: management of therapy complications
Procedure: physical therapy
Other: questionnaire administration
Procedure: assessment of therapy complications
Procedure: management of therapy complications
Other: educational intervention
Other: case management
Behavioral: telephone-based intervention
Procedure: assessment of therapy complications
Procedure: assessment of therapy complications
Procedure: quality-of-life assessment
Arm III (enhanced usual, RCM, PCM)
Experimental group
Description:
Patients undergo enhanced usual care as in Arm I, participate in an individualized conditioning program coordinated by the FCM as in Arm II, and receive optimized pain management through a nurse Pain Care Manager (PCM) for 6 months.
Treatment:
Procedure: management of therapy complications
Procedure: management of therapy complications
Procedure: physical therapy
Other: questionnaire administration
Procedure: assessment of therapy complications
Procedure: management of therapy complications
Other: educational intervention
Other: case management
Behavioral: telephone-based intervention
Procedure: assessment of therapy complications
Procedure: assessment of therapy complications
Procedure: quality-of-life assessment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems